ID

15177

Descripción

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Palabras clave

Versiones (1)
  1. 21/5/16 21/5/16 -
Subido en

21 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC-ND 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441

Inglés

Protocol IB AIEOP-BFM ALL 2009 NCT01117441

1 formularios  
Patient Information
Descripción

Patient Information

Alias
UMLS CUI-1
C1955348
Stud.-Nr. (Pat.-ID)
Descripción

Patient ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Patient date of birth
Descripción

Patient birthday

Tipo de datos

date

Alias
UMLS CUI [1]
C0421451
Body weight
Descripción

Weight

Tipo de datos

float

Unidades de medida
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Body height
Descripción

Height

Tipo de datos

float

Unidades de medida
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body surface
Descripción

Body surface

Tipo de datos

float

Unidades de medida
  • mˆ2
Alias
UMLS CUI [1]
C0005902
mˆ2
Chemotherapy Regimen
Descripción

Chemotherapy Regimen

Alias
UMLS CUI-1
C0392920
Cyclophosphamide administration form p.i. (1h) (+ MESNA)
Descripción

CPM: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C1827465
Cyclophosphamide 1000 mg/mˆ2/ED
Descripción

CPM: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0178602
mg
Cyclophosphamide Date of administration
Descripción

CPM: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C2584899
ARA-C administration form i.v.
Descripción

ARA-C: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C0013153
ARA-C dosage 75 mg/mˆ2/ED
Descripción

ARA-C: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C0178602
mg
ARA-C Date of administration
Descripción

ARA-C: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C2584899
6-MP administration form p.o. (28d)
Descripción

6-MP: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0000618
UMLS CUI [1,2]
C0013153
6-MP dosage 60 mg/mˆ2/d
Descripción

6-MP: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0000618
UMLS CUI [1,2]
C0178602
mg
6-MP Start date of therapy
Descripción

6-MP: start date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0000618
UMLS CUI [1,2]
C0808070
6-MP End date of therapy
Descripción

6-MP: end date

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
MTX administration form i.th
Descripción

MTX: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0677897
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
Descripción

MTX: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
mg
MTX Date of administration (while MTX infusion)
Descripción

MTX: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2584899
Hospitalization
Descripción

Hospitalization

Alias
UMLS CUI-1
C0019993
If member of randomization group R-HR, specify: Number of Nights in Hospital (Day 36 until start of HR-Block)
Descripción

Hospital nights

Tipo de datos

float

Unidades de medida
  • nights
Alias
UMLS CUI [1]
C0420496
nights
Identification and Signature
Descripción

Identification and Signature

Alias
UMLS CUI-1
C0205396
UMLS CUI-3
C1519316
Date and signature of the doctor who calculated and created chemotherapy regimen
Descripción

Chemotherapy creator: signature

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1707531
UMLS CUI [2]
C1519316
Date and signature of the person who administered chemotherapy
Descripción

Chemotherapy administration: signature

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1533734
UMLS CUI [2]
C1519316
Volver a la parte superior de la página

Similar models

Protocol IB AIEOP-BFM ALL 2009 NCT01117441

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient ID
Item
Stud.-Nr. (Pat.-ID)
text
C2348585 (UMLS CUI [1])
Patient birthday
Item
Patient date of birth
date
C0421451 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Height
Item
Body height
float
C0005890 (UMLS CUI [1])
Body surface
Item
Body surface
float
C0005902 (UMLS CUI [1])
Item Group
Chemotherapy Regimen
C0392920 (UMLS CUI-1)
CPM: administration form
Item
Cyclophosphamide administration form p.i. (1h) (+ MESNA)
boolean
C0010583 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
CPM: dosage
Item
Cyclophosphamide 1000 mg/mˆ2/ED
float
C0010583 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
CPM: date of administration
Item
Cyclophosphamide Date of administration
date
C0010583 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
ARA-C: administration form
Item
ARA-C administration form i.v.
boolean
C0010711 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
ARA-C: dosage
Item
ARA-C dosage 75 mg/mˆ2/ED
float
C0010711 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
ARA-C: date of administration
Item
ARA-C Date of administration
date
C0010711 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
6-MP: administration form
Item
6-MP administration form p.o. (28d)
boolean
C0000618 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
6-MP: dosage
Item
6-MP dosage 60 mg/mˆ2/d
float
C0000618 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
6-MP: start date
Item
6-MP Start date of therapy
date
C0000618 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
6-MP: end date
Item
6-MP End date of therapy
date
C0806020 (UMLS CUI [1])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration (while MTX infusion)
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Item Group
Hospitalization
C0019993 (UMLS CUI-1)
Hospital nights
Item
If member of randomization group R-HR, specify: Number of Nights in Hospital (Day 36 until start of HR-Block)
float
C0420496 (UMLS CUI [1])
Item Group
Identification and Signature
C0205396 (UMLS CUI-1)
C1519316 (UMLS CUI-3)
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial